TransMedics Group Inc (TMDX)
NASDAQ:TMDX
US Market
Holding TMDX?
Track your performance easily

TransMedics Group (TMDX) Financial Statements

723 Followers

TransMedics Group Financial Overview

TransMedics Group's market cap is currently ―. The company's EPS TTM is $0.035; its P/E ratio is 4,621.85; TransMedics Group is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $0.30. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 114.31M$ 96.85M$ 81.17M$ 66.43M$ 52.47M
Gross Profit$ 69.26M$ 59.96M$ 78.58M$ 40.66M$ 52.47M
EBIT$ 15.78M$ 12.42M$ 7.47M$ -23.34M$ 1.52M
EBITDA$ 20.38M$ 16.72M$ 11.07M$ -21.45M$ 2.92M
Net Income Common Stockholders$ 12.19M$ 12.20M$ 4.03M$ 29.00M$ -1.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 362.80M$ 350.20M$ 394.80M$ 427.10M$ 582.20M
Total Assets$ 758.58M$ 723.83M$ 706.05M$ 689.23M$ 690.35M
Total Debt$ 516.49M$ 516.22M$ 515.95M$ 515.65M$ 515.01M
Net Debt$ 153.69M$ 166.02M$ 121.15M$ 88.55M$ -67.19M
Total Liabilities$ 568.68M$ 564.36M$ 568.85M$ 562.77M$ 545.14M
Stockholders Equity$ 189.89M$ 159.47M$ 137.20M$ 126.46M$ 145.23M
Cash Flow-
Free Cash Flow$ 1.96M$ -47.61M$ -33.51M$ -114.59M$ -7.18M
Operating Cash Flow$ 25.72M$ -3.44M$ 8.30M$ -6.87M$ -5.80M
Investing Cash Flow$ -23.76M$ -44.17M$ -41.82M$ -149.83M$ -1.38M
Financing Cash Flow$ 10.64M$ 3.19M$ 924.00K$ 1.52M$ 394.01M
Currency in USD

TransMedics Group Earnings and Revenue History

TransMedics Group Debt to Assets

TransMedics Group Cash Flow

TransMedics Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis